Siemens IMMULITE CEA Assay Recalled for Biotin Interference Risk
Siemens Healthcare Diagnostics is recalling IMMULITE CEA assays because biotin interference thresholds are not listed in the instructions, potentially affecting test accuracy.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a labeling omission regarding biotin interference thresholds. No illnesses or injuries are reported, and the risk is related to test accuracy rather than direct physical harm, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
Siemens Healthcare Diagnostics, Inc. is recalling the IMMULITE /IMMULITE 1000 CEA assay. The recall is due to the fact that the concentration of biotin that does not interfere with the test is not currently listed in the instruction for use. This omission means the assay is susceptible to interference from biotin, which could impact the accuracy of the results.
The affected products include the IMMULITE /IMMULITE 1000 CEA assay with lot codes 0355, 0356, and 0357. The products were distributed nationwide in the United States, as well as in Canada, Mexico, and Thailand.
Healthcare providers and laboratories should stop using the affected lots and contact Siemens Healthcare Diagnostics for further instructions on how to proceed. This recall is a precautionary measure to ensure that patients are not exposed to inaccurate test results due to biotin interference.
The recalled product
- Product
- IMMULITE ¿ /IMMULITE ¿ 1000 CEA
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- CEA
- CEA (IMMULITE/IMMULITE 1000
- LKCE1)
- (IMMULITE 2000/IMMULITE 2000 XPi
- LKCE2
- LKCE6) Lot codes: 0355 0356 0357
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 24 recalled by Siemens Healthcare Diagnostics, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 24 products in this recall →Related recalls
Same manufacturer · Siemens Healthcare Diagnostics, Inc.
See all →- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
Same hazard · biotin interference
See all →- HighBeckman Coulter Access Free T4 Thyroxine Assay Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- HighBeckman Coulter Access Thyroglobulin Antibody II Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- ModerateBeckman Coulter Access Total T3 Assay Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- ModerateBeckman Coulter Free T3 Immunoassay Recalled for Biotin Interference
FDA (Devices) · 2020-06-10
- ModerateBeckman Coulter Access GI Monitor Cancer Antigen 19-9 Recalled for Biotin Interference
FDA (Devices) · 2020-06-10